本地零售點
了解口服避孕藥新標示要求
根據衞生署的最新規定，從2025年6月28日起，所有原屬非毒藥類的口服避孕藥將被重新分類為《藥劑業及毒藥條例》（第138章）第二級毒藥，包括拜耳旗下的品牌如優悅®、優思明®和Microgynon®，這些藥物將僅可在持牌藥房和藥店銷售。
避孕藥的包裝上亦必須根據規定，標示額外的字句以提醒在首次服用前應接受醫護評估。
了解更多關於新包裝的信息，請點擊以下連結：https://www.yaz.hk/package 或致電拜耳避孕藥查詢熱線8100 2755查詢。
Understanding the New Labeling Requirements for Oral Contraceptives
According to the latest regulations from the Department of Health, starting from 28th June, 2025, all oral contraceptives that were previously classified as non-poisons will be reclassified as Part 2 poisons under the Pharmacy and Poisons Ordinance (Cap. 138). This includes Bayer brands such as Yaz®, Yasmin®, and Microgynon®, which will only be available for sale at licensed pharmacies and drugstores.
These packages must include additional labeling as required by regulations to remind that medical assessment should be conducted before the first use.
To learn more about the new packaging, please click the following link: https://www.yaz.hk/package , or call the Bayer contraceptive inquiry hotline at 8100 2755.
優悅及優思明
特約社區藥房銷售點
初次服用避孕藥小貼士服用初期妳可能會出現輕微反應如頭痛、不規則陰道出血、嘔心等，這一般不會對身體產生負面影響15，應繼續照常服藥，這些反應通常會在服用的首數個月後消失。如情況持續、加重或再次出現，請立即聯絡妳的醫生。7,22
